{
    "2020-06-16": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Abbott's Libre 2 iCGM Gets FDA Nod to Better Manage Diabetes",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Libre 2",
                        "FDA",
                        "Diabetes"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "New Data Show Use of Abbott's FreeStyleÂ® Libre System Reduces All-Cause, Diabetic Ketoacidosis-Related Hospitalization Rates and Acute Diabetes Events",
                "features": {
                    "keywords": [
                        "Abbott",
                        "FreeStyle Libre",
                        "Hospitalization Rates",
                        "Diabetes Events"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "FOCUS-U.S. health insurers may balk at paying for coronavirus antibody testing",
                "features": {
                    "keywords": [
                        "U.S.",
                        "health insurers",
                        "coronavirus",
                        "antibody testing"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "insurance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "UK antibody test access stokes frustration and confusion",
                "features": {
                    "keywords": [
                        "UK",
                        "antibody test",
                        "frustration",
                        "confusion"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "public health"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Delay and confusion about finding a reliable antibody test in the UK",
                "features": {
                    "keywords": [
                        "UK",
                        "antibody test",
                        "delay",
                        "confusion"
                    ],
                    "sentiment_score": -0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "public health"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}